Abdulkarim H. Alshammari
Arar, 73213, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Multi-omics profiling of oxeiptosis-associated biomarkers in cancer.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: May 07, 2026
Circulating NETosis biomarkers in oncology.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: May 07, 2026
C-Reactive Protein-to-Albumin Ratio as a Prognostic Marker in ICU Patients with Pre-Existing Hypertension and Diabetes.
Journal: Journal of clinical medicine
Published: March 15, 2026
Knowledge, attitudes, and practices toward xylometazoline nasal spray use among adults in Saudi Arabia: a cross-sectional survey.
Journal: Frontiers in pharmacology
Published: March 02, 2026
Editorial Expression of Concern: Tailored therapies for triple‑negative breast cancer: current landscape and future perceptions.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 17, 2026
Impact of pharmacist counseling intervention to improve health-related quality of life in pulmonary tuberculosis: a randomized controlled trial.
Journal: IJID regions
Published: October 25, 2025
Epiafzelechin, a Flavanol, Regulates Lipid Homeostasis Through Modulation of HMGCR, PCSK9, and PPAR-α: Mechanistic Insights and Therapeutic Implications.
Journal: Cardiovascular therapeutics
Published: May 28, 2025
Exploring the Healing Potential of Aqueous Extract of Baccaurea ramiflora Leaves in Inflammation: A Cytokine and Prostaglandin Modulator.
Journal: Food science & nutrition
Published: February 19, 2025
Comprehensive safety assessment and therapeutic potential of Pediococcus acidilactici NMCC-B in attenuating arthritis progression.
Journal: PloS one
Published: January 08, 2025
Tailored therapies for triple-negative breast cancer: current landscape and future perceptions.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: October 30, 2024
Cannabigerol and Cannabinoid Receptors in Major Depressive Disorder: Network Pharmacology, Molecular Docking, and In-vivo Analysis.
Journal: Current drug discovery technologies
Published: October 24, 2024
Unraveling the mechanisms of glioblastoma's resistance: investigating the influence of tumor suppressor p53 and non-coding RNAs.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 14, 2024
Last Updated: 09/26/2026